This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: stent

November 2017 Br J Cardiol 2017;24:129

REDUCE shows non-inferiority of short versus long DAPT in acute coronary syndrome

BJC Staff

Abstract

The COMBO™ dual therapy stent REDUCE (Short-term Dual Anti Platelet Therapy in Patients with ACS Treated with the COMBO Dual-therapy Stent), a physician-initiated, prospective, multi-centre, randomised study, was conducted in 36 hospitals in Europe and Asia, enrolling a total of 1,496 ACS patients. The study was designed to demonstrate non-inferiority of a strategy of short-term (three months) dual antiplatelet therapy (DAPT) compared to standard 12-month DAPT in patients with ACS treated with a dual-therapy stent. The stent used in the study COMBO™ (OrbusNeich) is a sirolimus-eluting stent with an abluminal biodegradable polymer matrix,

| Full text

October 2017

ESC 2017: RE-DUAL PCI shows benefits for dabigatran

BJC staff

Abstract

Approximately 20–30% of patients with AF, who are continuously taking an oral anticoagulant to reduce their risk of AF-related stroke, have coexisting coronary artery disease and may require PCI. The current practice of administering triple therapy with warfarin and two antiplatelet agents in patients with AF after a PCI is associated with high rates of major bleeding. RE-DUAL PCI tested an alternative treatment strategy: dual therapy with dabigatran and a single antiplatelet agent (P2Y12 inhibitor). Selected for one of the meeting’s hotline sessions and simultaneously published in the New England Journal of Medicine (https://doi.org/10.

| Full text
News from the American Heart Association Scientific Sessions 2010

February 2011 Br J Cardiol 2011;18:11-3

News from the American Heart Association Scientific Sessions 2010

Abstract

Highlights of the American Heart Association 2010 meeting held in November 2010, in Chicago, USA, included a breakthrough for the treatment of resistant hypertension, and another oral anticoagulant that could be used instead of warfarin in atrial fibrillation patients, without the need for monitoring. RAFT: CRT reduces deaths and hospitalisations in mild heart failure Adding cardiac-resynchronisation therapy (CRT) to implantable cardioverter defibrillator (ICD) and medication, led to a reduction in deaths and heart failure hospitalistions among patients with mild-to-moderate symptoms of heart failure in the RAFT (Resynchronisation-Defibrilla

| Full text
In brief

May 2010 Br J Cardiol 2010;17:117

In brief

BJ Cardio Staff

Abstract

New pocket-sized visualisation tool This new pocket-sized visualisation tool provides ultrasound technology at the point-of-care. Similar in size to a mobile phone and weighing less than one pound, it can give high quality colour images enabling physicians to take a quick look inside the body and detect disease earlier. Vscan™ is marketed by GE Healthcare and has received the CE Mark by the European Union. Heart failure report published A comprehensive review of the quality of heart failure care in England Bridging the quality gap: heart failure, has been published by The Health Foundation. It highlights that prevention is key to imp

| Full text

January 2008 Br J Cardiol 2008;15:7-11

New ‘healing’ stent looks promising

BJCardio editorial team

Abstract

Table 1. Results at 10 months In the current study, the GenousTM stent was associated with significantly fewer major adverse cardiac events (MACE) than the TaxusTMor CypherTM drug-eluting stents. The study, presented at the recent Italian Society of Invasive Cardiology by Dr Federico Piscione (Federico II University of Naples, Italy) involved 195 high-risk patients who received either a GenousTM, TaxusTM or CypherTM stent. Dual antiplatelet therapy was given for one month to the patients receiving a GenousTM stent and for nine months to those given one of the drug-eluting stents. “GenousTM is a viable alternative to drug-eluting stents, whi

| Full text

July 2006 Br J Cardiol (Acute Interv Cardiol) 2006;13:AIC 46–AIC 47

Double-barrel lumen during recanalisation of a chronically occluded stent in a saphenous vein graft

Jun Tanigawa, Omer Goktekin, Carlo Di Mario

Abstract

No content available

| Full text

February 2003 Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 28–AIC 32

‘Real world’ small vessel coronary artery stenting: an analysis

Allison Morton, Thomas Papadopoulos, Clare Wales, Robert Bowes, Stephen Campbell, David Oakley, Nigel Wheeldon, Christopher Newman, David Crossman, David Cumberland, Julian Gunn

Abstract

No content available

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now